|
Bengaluru, India, July 04, 2018
“Biocon has received the EU GMP certification for its Sterile Drug Product manufacturing facility in Bangalore, which was inspected by the European agencies in March 2018. This facility is used for the manufacture of Biocon’s portfolio of biosimilars. Biocon remains committed to global standards of quality and compliance.” -Company Spokesperson
|
